Titre:preclinical contract research organization cro for metabolic diseases - physioge
La description :a contract research organization specializing in pharmacology & efficacy services in the field of cardiometabolic disorders, such as diabetes, obesity, dyslipidemia, atherosclerosis, steatohepatitis a...
Classement Alexa Global: # 14,290,940
Server:Apache/2.2...
L'adresse IP principale: 178.32.28.118,Votre serveur France,Roubaix
ISP:OVH SAS TLD:com Code postal:fr
Ce rapport est mis à jour en 03-Nov-2018
Created Date:
2002-07-23
Changed Date:
2017-06-13
Données techniques du physiogenex.com
Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations.
Notre service GeoIP a trouvé l'hôte physiogenex.com.Actuellement, hébergé dans France et son fournisseur de services est OVH SAS .
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache/2.2 contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
MX preference = 10, mail exchanger = physiogenex-com.mail.eo.outlook.com.
HtmlToText
about company overview board of directors scientific advisory board partners our values consultancy research services insulin resistance – diabetes dyslipidemia – atherosclerosis nash – fibrosis obesity immuno-metabolism nutraceuticals preclinical imaging quality commitments facilities innovation publications news and events jobs consult our offers and apply submit your candidature contact us select page the scientific focus adapted to express the optimum potential of your molecule marketing: unparalleled vision in metabolic disorders and risk assessment expertise for post-marketing studies and drug repositioning. heart artery macrophage liver muscle pancreas adipose tissue preclinical development: in-house predictive models and tracer technologies enable the generation of proof of concept efficacy data for your drugs. discovery: screening and lead validation utilize a dedicated research platform which combine with our focused scientific vision. home physiogenex is a preclinical contract research organization (cro) that offers outstanding consultancy and research services, specializing in metabolic disorders such as diabetes , obesity , liver diseases (nash) , dyslipidemia , atherosclerosis and cardiovascular complications. more than just a cro , we are your r&d partner of choice to target your specific needs. our models and technologies are customized and we deliver unparalleled scientific expertise for r&d, preclinical development, post-marketing studies and drug repositioning. we also offer in vivo preclinical imaging services. we provide both the biopharmaceutical and nutraceutical companies with optimal and reliable solutions for successful strategic decision-making. r&d, preclinical and post marketing studies diabetes insulin resistance obesity liver diseases nafld hepatic steatosis to fibrosis dyslipidemia atherosclerosis diabetic nephropathy animal models from basic to predictive in-house models experimental platform from gold-standard to innovative assays scientific expertise and translational vision news, events and publications physiogenex and its industry partners to present at the asn kidney week 2018, october the 27th, 2018, san diego, ca, usa. physiogenex to present at the keystone conference on drivers of type 2 diabetes in seoul, korea – october 7-12th, 2018 physiogenex to present at the aasld single topic conference on hepatic fibrosis in dallas, tx, usa, sept. 14-15th 2018 subscribe to our scientific publications and webinars top site map legal mentions rss linkedin viadeo twitter google member of this website uses cookies to improve your experience. we'll assume you're ok with this, but you can opt-out if you wish. accept read more nunc ut ut elit. ut mattis elit. nec lorem odio luctus
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
Domain Name: PHYSIOGENEX.COM
Registry Domain ID: 88652359_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.gandi.net
Registrar URL: http://www.gandi.net
Updated Date: 2017-06-13T11:59:06Z
Creation Date: 2002-07-23T10:17:37Z
Registry Expiry Date: 2018-07-23T10:17:37Z
Registrar: Gandi SAS
Registrar IANA ID: 81
Registrar Abuse Contact Email: abuse@support.gandi.net
Registrar Abuse Contact Phone: +33.170377661
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: A.DNS.GANDI.NET
Name Server: B.DNS.GANDI.NET
Name Server: C.DNS.GANDI.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-09-05T16:20:17Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR Gandi SAS
SERVERS
SERVER com.whois-servers.net
ARGS domain =physiogenex.com
PORT 43
TYPE domain RegrInfo DOMAIN
NAME physiogenex.com
CHANGED 2017-06-13
CREATED 2002-07-23
STATUS clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Nous utilisons des cookies pour personnaliser votre expérience sur notre site. En poursuivant votre navigation, vous acceptez cette utilisation. Apprendre encore plus
physiogenex.com rapport :
Visitez le site